IPOS - Coya Therapeutics prices ~$15.2M Nasdaq IPO

• Coya Therapeutics ( COYA ) priced its Nasdaq IPO to raise about $15.25M in gross proceeds.
• The ALS drug developer is offering 3.05M common shares and accompanying warrants to buy up to 1.525M shares.
• The company added that warrants are being sold at the rate of one warrant for every two shares bought in the offering, with each full warrant having an exercise price of $7.50 per share.
• Each common stock and accompanying warrant is being sold at a combined offering price of $5, for gross proceeds of ~$15.25M.
• The company has granted the underwriters a 30-day option to buy up to an additional 290K shares and/or warrants to buy 145K shares.
• The shares are expected to begin trading on the Nasdaq Capital Market today (Dec. 29).
• Coya plans to use the net proceeds, ~$13.2M, to advance its programs in preclinical studies into clinical trials, to advance discovery and candidate selection stage programs, and for general corporate purposes.

For further details see: